ENTERA BIO LTD ENTX
SHS · Common Stock · CUSIP M40527109
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.72. Options: 5 managers hold calls ($1.2m notional), 5 hold puts ($628.0k).
Trends to Q3 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 4 |
| Q1 2020 | 4 |
| Q2 2020 | 6 |
| Q3 2020 | 6 |
| Q4 2020 | 6 |
| Q1 2021 | 9 |
| Q2 2021 | 15 |
| Q3 2021 | 15 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 1 | 1 |
| Q2 2020 | 2 | 2 |
| Q3 2020 | 2 | 3 |
| Q4 2020 | 2 | 3 |
| Q1 2021 | 7 | 2 |
| Q2 2021 | 10 | 7 |
| Q3 2021 | 7 | 8 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q4 2020 | $0 | $0 | — |
| Q1 2021 | $0 | $0 | — |
| Q2 2021 | $1.7m | $1.3m | 0.75 |
| Q3 2021 | $1.2m | $628.0k | 0.51 |
Biggest buyers
| ARK Investment Management LLC | New | +683.0k |
| BANK OF AMERICA CORP /DE/ | New | +16.2k |
| JANE STREET GROUP, LLC | New | +11.6k |
| SIMPLEX TRADING, LLC | Added | +3.7k |
| MORGAN STANLEY | Added | +3.2k |
| ROYAL BANK OF CANADA | New | +1.9k |
| JPMORGAN CHASE & CO | New | +2 |
Biggest sellers
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold out | -66.7k |
| Verition Fund Management LLC | Sold out | -30.5k |
| CITADEL ADVISORS LLC | Reduced | -27.3k |
| MILLENNIUM MANAGEMENT LLC | Reduced | -15.9k |
| XTX Topco Ltd | Sold out | -10.4k |
| Tower Research Capital LLC (TRC) | Sold out | -9.0k |
| Cutler Group LLC / CA | Sold out | -4.6k |
| UBS Group AG | Reduced | -457 |
Biggest calls
| CITADEL ADVISORS LLC | Added | $717.0k152.2k shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | $423.0k89.9k shares |
| GROUP ONE TRADING LLC | Added | $55.0k11.7k shares |
| SIMPLEX TRADING, LLC | Reduced | $42.0k6.7k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Biggest puts
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | $283.0k60.1k shares |
| CITADEL ADVISORS LLC | Reduced | $209.0k44.4k shares |
| SIMPLEX TRADING, LLC | Added | $120.0k19.2k shares |
| GROUP ONE TRADING LLC | Reduced | $16.0k3.5k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
BIOTECHNOLOGY VALUE FUND L P
13D · may seek influence
new · filed 2026-08-04
Stated purposeThe Reporting Persons purchased the securities reported owned herein based on the Reporting Persons' belief that such securities, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable. April Securities Purchase Agreement and Registration Rights Agreement On April 1, 2026, … Full filing |
10.0% |
| OPKO HEALTH, INC. 13G · passive investor new · filed 2025-04-02 | 8.1% |
| TCG Crossover GP III, LLC 13G · passive investor new · filed 2026-08-04 | 7.1% |
| Vivo Opportunity Fund Holdings, L.P. 13G · passive investor new · filed 2026-08-04 | 6.9% |
Fell to 5% or below in the last year: Longitude Capital Partners V, LLC (4.6%, 2026-08-04), Seven Fleet Capital Management LP (4.1%, 2026-08-04)
Insider purchases and sales in Q3 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q3 2021.
Holders, Q3 2021
| Manager | Shares | Change |
|---|---|---|
| Knoll Capital Management, LLC 5.84% of their portfolio | 2.5m $11.7m | Unchanged |
| RA CAPITAL MANAGEMENT, L.P. 0.15% of their portfolio | 2.4m $11.1m | Unchanged |
| ARK Investment Management LLC 0.01% of their portfolio | 683.0k $3.2m | New |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 39.9k $188.0k | Reduced -27.3k |
| SIMPLEX TRADING, LLC 0.00% of their portfolio | 19.4k $122.0k | Added +3.7k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 18.8k $89.0k | Reduced -15.9k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 17.6k $82.0k | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 16.2k $76.0k | New |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 0.00% of their portfolio | 14.4k $68.0k | Unchanged |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 11.6k $54.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 5.4k $25.0k | Added +3.2k |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 1.9k $9.0k | New |
| UBS Group AG 0.00% of their portfolio | 565 $3.0k | Reduced -457 |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 2 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |